You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

ABITREXATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Abitrexate patents expire, and what generic alternatives are available?

Abitrexate is a drug marketed by Abic and is included in four NDAs.

The generic ingredient in ABITREXATE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Abitrexate

A generic version of ABITREXATE was approved as methotrexate sodium by HIKMA on September 16th, 1986.

  Try a Trial

Summary for ABITREXATE
Drug patent expirations by year for ABITREXATE
Recent Clinical Trials for ABITREXATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Oncology GroupPhase 2/Phase 3
Children's Oncology GroupPhase 1/Phase 2
City of Hope Medical CenterPhase 1

See all ABITREXATE clinical trials

US Patents and Regulatory Information for ABITREXATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abic ABITREXATE methotrexate sodium INJECTABLE;INJECTION 089161-001 Mar 10, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abic ABITREXATE methotrexate sodium INJECTABLE;INJECTION 089356-001 Jul 17, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abic ABITREXATE methotrexate sodium INJECTABLE;INJECTION 089354-001 Jul 17, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abic ABITREXATE methotrexate sodium INJECTABLE;INJECTION 089355-001 Jul 17, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.